CS
EIGR

Candriam SCA’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Candriam SCA’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-411
Closed -$3.51M – 667
2015
Q1 		$3.51M Buy
411
+55
+15% +$469K 0.07% 310
2014
Q4 		$3.13M Buy
+356
New +$3.13M 0.07% 301